Streetbeat News

Products Services

AMIX

Autonomix shares are trading higher after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:05 pm

AMIX

Autonomix has entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:05 pm

ENPH

Enphase Energy has launched the CS-100 EV Charger aimed at U.S. commercial fleets, expanding its product offerings in the electric vehicle market.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:04 pm

TGB

Taseko Mines Limited reported Q2 production results of 20 million pounds of copper and 185,000 pounds of molybdenum. Production was impacted by mill downtime due to the relocation of the in-pit crusher and maintenance activities, as well as an 18-day strike by the unionized workforce in June. The in-pit crusher move and maintenance work have been completed, and Concentrator #1 is ramping up to full capacity.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:04 pm

ASMB

Assembly Biosciences (ASMB) is set to present preclinical data on its investigational helicase-primase inhibitors, which could have significant implications for the company's future product pipeline and market position.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:04 pm

HRTX

Heron Therapeutics announced that its product ZYNRELEF has been included in the proposed 2025 non-opioid policy for pain relief under Medicare OPPS and ASC payment systems. This policy is set to be effective from April 1, 2025, and is based on ZYNRELEF's postoperative pain indication and its potential to reduce opioid use.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:03 pm

CKPT

FBIO

GC Cell and Checkpoint Therapeutics are collaborating to explore the combined therapeutic potential of Checkpoint's anti-PD-L1 drug, cosibelimab, with GC Cell's autologous T cell therapy, Immuncell-LC.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:03 pm

PLRX

Pliant Therapeutics announced positive 24-week data from its Phase 2a trial of bexotegrast in patients with primary sclerosing cholangitis (PSC). The 320 mg dose was well tolerated and showed significant improvements in liver stiffness, alkaline phosphatase levels, and hepatocyte function compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:02 pm

HPQ

HP has introduced the world's highest performance AI PC, the OmniBook Ultra, which features 55 TOPS NPU performance and Wolf Security. The new AI platform includes apps from Beautiful.ai, Loccus.ai, Luminar Neo, Omnibridge, Polymer, and Virtual Sapiens, aimed at enhancing productivity and content creation.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 12:02 pm

BLK

COIN

DJT

FSLR

GS

QQQ

RUN

SPY

U.S. stocks are set for a positive start ahead of Federal Reserve Chairman Jerome Powell's speech and key earnings reports. Futures for major indices are up, with the SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) showing gains in premarket trading. Trump Media & Technology Group Corp. (DJT) surged over 50% following improved odds for Donald Trump. Crypto-linked stocks like Coinbase Global, Inc. (COIN) rallied, while solar stocks Sunrun Inc. (RUN) and First Solar, Inc. (FSLR) fell. Goldman Sachs Group, Inc. (GS) and BlackRock, Inc. (BLK) are set to announce quarterly results.

Portfolio Pulse from Shanthi Rexaline

July 15, 2024 | 11:52 am